A shorter radiation therapy schedule can be as effective as a conventional schedule for men with low-risk prostate cancer
RTOG 0415 data indicates treatment delivered over five and one-half weeks results in similar disease-free survival rates as an eight-week scheduleHypofractionated radiation therapy (RT), which is delivered in larger doses over a shorter time period than conventional RT, results in similar rates of cure and side effects compared to a longer treatment schedule for some men with low-risk prostate cancer, according to research presented today at the American Society for Radiation Oncology’s (ASTRO’s) 57th Annual Meeting. RTOG 0415 was a phase III study conducted from April 2006 to December